Recombinant kinase activity profile of Gö 6983
Biochemical assay · Recombinant human kinase panel; selected PKC/PKD, GSK3 and RSK measurements from a 300-kinase screen [1]
One coherent single-concentration kinase-panel experiment. PKC inhibition varied across isoforms, and several non-PKC kinases were inhibited at the same concentration. Values are mean percent activity remaining, not IC50 values. Weaker PKCγ/PKCζ/PKCμ responses and non-PKC effects are retained. The authors caution that 10 µM ATP, truncated constructs and incomplete kinome coverage limit extrapolation to cells.
| Endpoint | Reported result | Reference |
|---|---|---|
| PKCa substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 3.141353019186526% (mean of two replicates; spreadsheet value) | [1] |
| PKCb1 substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 19.289364906301323% (mean of two replicates; spreadsheet value) | [1] |
| PKCb2 substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 14.245029883712608% (mean of two replicates; spreadsheet value) | [1] |
| PKCd substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 1.6733338474784611% (mean of two replicates; spreadsheet value) | [1] |
| PKCepsilon substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 14.641380712434398% (mean of two replicates; spreadsheet value) | [1] |
| PKCeta substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 6.845200277108306% (mean of two replicates; spreadsheet value) | [1] |
| PKCg substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 54.020246583639526% (mean of two replicates; spreadsheet value) | [1] |
| PKCiota substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 67.62486156425798% (mean of two replicates; spreadsheet value) | [1] |
| PKCmu/PRKD1 substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 68.84923136369665% (mean of two replicates; spreadsheet value) | [1] |
| PKCnu/PRKD3 substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 91.9319947451007% (mean of two replicates; spreadsheet value) | [1] |
| PKCtheta substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 4.500038258806724% (mean of two replicates; spreadsheet value) | [1] |
| PKCzeta substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 78.22843922361025% (mean of two replicates; spreadsheet value) | [1] |
| PKD2/PRKD2 substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 92.29379875240141% (mean of two replicates; spreadsheet value) | [1] |
| GSK3a substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 14.042058290843638% (mean of two replicates; spreadsheet value) | [1] |
| GSK3b substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 31.977321635299703% (mean of two replicates; spreadsheet value) | [1] |
| RSK1 substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 15.987054177267057% (mean of two replicates; spreadsheet value) | [1] |
| RSK2 substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 6.550063057159029% (mean of two replicates; spreadsheet value) | [1] |
| RSK3 substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 5.457282901495947% (mean of two replicates; spreadsheet value) | [1] |
| RSK4 substrate-phosphorylation activity remaining relative to solvent control | remaining kinase activity (%) 4.524780576648927% (mean of two replicates; spreadsheet value) | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.5 µM Gö 6983; 10 µM ATP
- Exposure duration
- Approximately 20 min before ATP addition, followed by 120 min reaction at room temperature
- Method
- Radiometric substrate-phosphorylation HotSpot assay
- Vehicle
- 1% DMSO in reaction buffer; results normalized to DMSO control
- Reported limits
- Kinase-specific substrates/construct boundaries in Supplementary Table 2 were not extracted. The source reports average compound-library purity >98%, which is not a GO6983-specific certificate.
Methods and source locations
Compound reported in the paper: Gö 6983; Compound label in the paper: Gö 6983; CAS 133053-19-7 in Supplementary Table 3
Compound-level biochemical evidence; no Adooq lot equivalence or cellular potency assumption.
Supplementary Table 3, Gö 6983 column BM; headers BM2–BM3; selected kinase rows; Results, A kinase-inhibitor interaction map; Methods, Kinase assays
PKCa substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCa row 224, Gö 6983 cell BM224; table header; Methods, Kinase assays
PKCb1 substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCb1 row 225, Gö 6983 cell BM225; table header; Methods, Kinase assays
PKCb2 substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCb2 row 226, Gö 6983 cell BM226; table header; Methods, Kinase assays
PKCd substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCd row 227, Gö 6983 cell BM227; table header; Methods, Kinase assays
PKCepsilon substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCepsilon row 228, Gö 6983 cell BM228; table header; Methods, Kinase assays
PKCeta substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCeta row 229, Gö 6983 cell BM229; table header; Methods, Kinase assays
PKCg substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCg row 230, Gö 6983 cell BM230; table header; Methods, Kinase assays
PKCiota substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCiota row 231, Gö 6983 cell BM231; table header; Methods, Kinase assays
PKCmu/PRKD1 substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCmu/PRKD1 row 232, Gö 6983 cell BM232; table header; Methods, Kinase assays
PKCnu/PRKD3 substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCnu/PRKD3 row 233, Gö 6983 cell BM233; table header; Methods, Kinase assays
PKCtheta substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCtheta row 234, Gö 6983 cell BM234; table header; Methods, Kinase assays
PKCzeta substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKCzeta row 235, Gö 6983 cell BM235; table header; Methods, Kinase assays
PKD2/PRKD2 substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, PKD2/PRKD2 row 236, Gö 6983 cell BM236; table header; Methods, Kinase assays
GSK3a substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, GSK3a row 124, Gö 6983 cell BM124; table header; Methods, Kinase assays
GSK3b substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, GSK3b row 125, Gö 6983 cell BM125; table header; Methods, Kinase assays
RSK1 substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, RSK1 row 255, Gö 6983 cell BM255; table header; Methods, Kinase assays
RSK2 substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, RSK2 row 256, Gö 6983 cell BM256; table header; Methods, Kinase assays
RSK3 substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, RSK3 row 257, Gö 6983 cell BM257; table header; Methods, Kinase assays
RSK4 substrate-phosphorylation activity remaining relative to solvent control: HotSpot radiometric kinase activity assay; 0.5 µM Gö 6983, 10 µM ATP; inactive-enzyme background subtraction and normalization to DMSO control. — Supplementary Table 3, RSK4 row 258, Gö 6983 cell BM258; table header; Methods, Kinase assays